IndraLab

Statements

P5091 increases the amount of CCDC6. 1 / 1

| 1

reach

"P5091 also enhances the sensitivity of lung neuroendocrine tumor cells to PARP inhibitors by diminishing CCDC6 levels and hampering HR repair, showing combined efficacy against lung neuroendocrine and CRPC [145, 147]."

38702734

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

P5091 increases the amount of CCDC6. 1 / 1

INDRA sources:

Databases

Reading